Skip to content

Asset turnover at other companies

Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
0.0×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
0.1×+0.1×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
0.7×+0.1×
Precigen logo
PrecigenPGEN
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
+0.5×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
0.5×+0.1×

Other financials

Income statement

See full
Revenue$53.0K-97.3%
Operating income-$14.9M-88.7%
Net income-$15.8M-92.6%
EPS (diluted)-$1.20-62.2%

Balance sheet

See full
Cash & equivalents$206.4M+173%
Total debt$584.0K
Total equity$232.3M+318%
Total assets$263.8M+232%

Cash flow

See full
Operating cash flow-$10.9M-60.5%
CapEx--100%
Free cash flow-$2.7M+72.0%

Valuation

See full
Market cap$1.7B+468%
Enterprise value$1.5B
P/S41.6×

Profitability

See full
Operating margin-183.2%-13.5pp
Net margin71.7%+40.4pp
FCF margin-99.8%-34.2pp

Returns & leverage

See full
Return on equity-34.2%
Debt / equity
Current ratio28.9×+20.0×

Where this comes from

Calculated from Palvella Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: Palvella Therapeutics’s 10-Q, filed May 15, 2024, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Palvella Therapeutics's asset turnover?
Palvella Therapeutics (PVLA) reported asset turnover of 0.7× in Q1 2024.
How has Palvella Therapeutics's asset turnover changed year-over-year?
Palvella Therapeutics's asset turnover increased by 376.8% year-over-year, from 0.2× to 0.7×.
What is the long-term trend for Palvella Therapeutics's asset turnover?
Over 3 years (2020 to 2023), Palvella Therapeutics's asset turnover has grown at a 51.6% compound annual growth rate (CAGR), from 0.2× to 0.8×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.